InvestorsHub Logo
Followers 59
Posts 11461
Boards Moderated 0
Alias Born 07/16/2006

Re: None

Sunday, 02/19/2017 7:25:29 PM

Sunday, February 19, 2017 7:25:29 PM

Post# of 20689
Teva's initial guidance, behind the numbers:

In other words, management is bracing for a -20% volume coupled with a -25% price which results in a revenue loss of 2$ billion and a cash flow loss of $1.6 billion.

(prior to latest news)